The Gut Microbiota and Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2017-03-29

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3233/JAD-161141PMID 28372330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-associated physiological and pathological changes at the blood–brain barrier: A review

  2017cited by this paper
• Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration

  2017cited by this paper
• Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

  2017cited by this paper
• The Human Intestinal Microbiome in Health and Disease.

  2016cited by this paper
• Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis.

  2016cited by this paper
• Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

  2016cited by this paper
• Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

  2016cited by this paper
• The Central Nervous System and the Gut Microbiome.

  2016cited by this paper
• Gut Microbiota and Extreme Longevity.

  2016cited by this paper
• Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance

  2016cited by this paper
• Gut Microbiota: A Contributing Factor to Obesity

  2016cited by this paper
• microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration

  2016cited by this paper
• Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

  2016cited by this paper
• The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

  2016cited by this paper
• Towards understanding brain-gut-microbiome connections in Alzheimer’s disease

  2016cited by this paper
• Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer’s Disease

  2016cited by this paper
• Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease

  2016cited by this paper
• The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease.

  2016cited by this paper
• Anti‐inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation

  2016cited by this paper
• Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans

  2016cited by this paper
• Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial

  2016cited by this paper
• Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.

  2016cited by this paper
• Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour.

  2015cited by this paper
• Autism spectrum disorders and intestinal microbiota

  2015cited by this paper
• Host microbiota constantly control maturation and function of microglia in the CNS

  2015cited by this paper
• The Microbiota and Microbiome in Aging: Potential Implications in Health and Age‐Related Diseases

  2015cited by this paper
• Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration

  2015cited by this paper
• Blood-brain barrier breakdown in the aging human hippocampus.

  2015cited by this paper
• Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.

  2015cited by this paper
• Adult Hippocampal Neurogenesis Is Regulated by the Microbiome.

  2015cited by this paper
• Brain-gut-microbiota axis in Parkinson's disease.

  2015cited by this paper
• Bifidobacteria modulate cognitive processes in an anxious mouse strain.

  2015cited by this paper
• Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).

  2015cited by this paper
• Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)

  2015cited by this paper
• Gut microbiota are related to Parkinson's disease and clinical phenotype

  2015cited by this paper
• Neurodegenerative diseases: expanding the prion concept.

  2015cited by this paper
• Fecal microbiota transplantation broadening its application beyond intestinal disorders.

  2015cited by this paper
• Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment

  2015cited by this paper
• Immune attack: the role of inflammation in Alzheimer disease

  2015cited by this paper
• The Gut-Brain Axis: The Missing Link in Depression

  2015cited by this paper
• Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

  2015cited by this paper
• Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity.

  2015cited by this paper
• Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.

  2015cited by this paper
• Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats.

  2015influential reference
• The effects of gut microbiota on CNS function in humans

  2014cited by this paper
• Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

  2014cited by this paper
• The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease

  2014cited by this paper
• Understanding gut microbiota in elderly's health will enable intervention through probiotics.

  2014cited by this paper
• Vascular hyperpermeability and aging.

  2014cited by this paper
• A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis.

  2014cited by this paper
• Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

  2014cited by this paper
• Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?

  2014cited by this paper
• Conference on 'Diet, gut microbiology and human health' Symposium 4: Manipulating the microbiome: health and therapeutic opportunities: Gut microbiota, the pharmabiotics they produce and host health

  2014cited by this paper
• Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases

  2014cited by this paper
• Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.

  2014cited by this paper
• Vagal pathways for microbiome-brain-gut axis communication.

  2014cited by this paper
• Correlation between the human fecal microbiota and depression

  2014cited by this paper
• Therapeutic potential of fecal microbiota transplantation.

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

  2013cited by this paper
• Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions

  2013cited by this paper
• Disease to Dirt: The Biology of Microbial Amyloids

  2013cited by this paper
• TREM2 signaling, miRNA-34a and the extinction of phagocytosis

  2013cited by this paper
• Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

  2013cited by this paper
• NMDA Receptor Activity in Neuropsychiatric Disorders

  2013cited by this paper
• Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa

  2013cited by this paper
• Current Status and Future Promise of the Human Microbiome

  2013cited by this paper
• The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner

  2013cited by this paper
• The gut microbiota, obesity and insulin resistance.

  2013cited by this paper
• Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

  2013cited by this paper
• Gut metagenome in European women with normal, impaired and diabetic glucose control

  2013cited by this paper
• BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

  2013cited by this paper
• Microbial amyloids--functions and interactions within the host.

  2013cited by this paper
• Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.

  2013cited by this paper
• Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?

  2013cited by this paper
• Blood–brain-barriers in aging and in Alzheimer’s disease

  2013cited by this paper
• Age-associated remodeling of the intestinal epithelial barrier.

  2013cited by this paper
• The global prevalence of dementia: A systematic review and metaanalysis

  2013cited by this paper
• The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes

  2013cited by this paper
• CD14 Protein Acts as an Adaptor Molecule for the Immune Recognition of Salmonella Curli Fibers*

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis

  2012cited by this paper
• A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathobiology and course.

  2012cited by this paper
• γ‐Aminobutyric acid production by culturable bacteria from the human intestine

  2012cited by this paper
• Microbial Amyloids Induce Interleukin 17A (IL-17A) and IL-22 Responses via Toll-Like Receptor 2 Activation in the Intestinal Mucosa

  2012cited by this paper
• Gut microbiota composition correlates with diet and health in the elderly

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse.

  2012cited by this paper
• Functional interactions between the gut microbiota and host metabolism

  2012cited by this paper
• Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

  2012cited by this paper
• Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

  2012cited by this paper
• Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results.

  2012cited by this paper
• The interplay between the intestinal microbiota and the brain

  2012cited by this paper
• A framework for human microbiome research

  2012cited by this paper
• Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa

  2012cited by this paper
• A metagenome-wide association study of gut microbiota in type 2 diabetes

  2012cited by this paper
• A Unifying Role for Prions in Neurodegenerative Diseases

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Reduced anxiety‐like behavior and central neurochemical change in germ‐free mice

  2011cited by this paper

• Neuroendocrine signaling as a pathological seed for the female bias of Alzheimer's disease and the concept of estrobolome.

  2026cites this paper
• The impact of microbiome dysbiosis on manganese-induced neurotoxicity: Brain metabolomics and multi-organ 16S rRNA profiling in mice.

  2026cites this paper
• Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.

  2026cites this paper
• A Narrative Review of Dietary, Lifestyle, and Other Complementary and Alternative Approaches in Alzheimer’s Disease and Related Dementias

  2026cites this paper
• Acer truncatum Bunge seed oil attenuates learning and memory impairment in AD mouse model via modulating gut microbiota and metabolism.

  2026cites this paper
• Climate change, gut microbiome, and epilepsy—New paradigms beyond the gut-brain axis

  2026cites this paper
• Permeability of the Blood–Brain Barrier (BBB) to Nanoparticles, Bacteria and Phages Studied in BBB Organoids Under Normoxic and Hypoxic Conditions In Vitro

  2026cites this paper
• The correlation and gut microbial characteristics in the whole spectrum of Alzheimer’s disease: a systematic review and meta-analysis

  2026cites this paper
• Electroacupuncture exerts neuroprotective effects and alters gut microbiota in a MPTP-induced mouse model of Parkinson’s disease

  2026cites this paper
• Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer's Diseases.

  2025cites this paper
• Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review

  2025cites this paper
• Convergence in Nanomedicine: Integrating Brain-Targeted Delivery and Gut Microbiota Modulation for Neurological Protection

  2025cites this paper
• Can bacteria control the human brain?

  2025influential citation
• Effects of the Curcuminoid and Non-Curcuminoid Compounds of Turmeric on the Gut Microbiome and Inflammation: Potential Use in the Treatment and Prevention of Disease.

  2025cites this paper
• Impact of Gut–Brain Axis and Probiotics on Alzheimer’s Disease

  2025cites this paper
• Targeting immune cell migration as therapy for inflammatory disease: a review

  2025cites this paper
• Intermittent supplementation with Akkermansia muciniphila and galactooligosaccharides modulates Alzheimer’s disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice

  2025cites this paper
• Haoya Wang Et Al.: Circadian Rhythm Disruption Promotes Tumor Progression Through Upregulated Glycolysis

  2025cites this paper
• Exploring the molecular intersection for hypertension, hyperlipidemia and their comorbid conditions through multi-omics approaches

  2025cites this paper
• Exploring causal gut-brain axes in Alzheimer's disease using mediation Mendelian randomization analysis

  2025cites this paper
• Plant-Derived Nutraceuticals in Mental Health and Brain Function: Mechanisms of Action and Therapeutic Potential

  2025cites this paper
• The Role of Oral and Gut Microbiota in Bone Health: Insights from Bacterial Extracellular Vesicles

  2025cites this paper
• The Association Between Body Weight Variability and Dementia and Cognitive Decline: A Systematic Review and Meta-Analysis of Cohort Studies With the GRADE Assessment.

  2025cites this paper
• Exploring the gut-brain-microbiome axis in Alzheimer's disease: Integrating metagenomics, metabolomics, and artificial intelligence for next-generation biomarker discovery

  2025cites this paper
• Fecal microbiota transplantation attenuates Alzheimer’s disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation

  2025cites this paper
• Enterococcus dysbiosis as a mediator of vitamin D deficiency-associated memory impairments

  2025cites this paper
• Effects of a healthy diet based on seed-rich vegetables on the gut microbiota and intrinsic brain activity in perimenopausal women: A pilot study on cognitive improvement

  2025cites this paper
• Effect of the Fatty Acid Intake on Cognitive Function Through Gut Microbiota and Circulating microRNAs Remodeling in Middle‐Aged and Elderly Overweight and Obese Population

  2025cites this paper
• Efficacy and Safety of MT104, A Dietary Supplement Based on Cuscuta Seeds and Heat-Killed Probiotics, on Cognitive Function in Patients with Mild Cognitive Impairment: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2025cites this paper
• The rise of probiotics as adjuvant therapeutics in Alzheimer’s disease

  2025cites this paper
• Gut Microbiota and Interorgan Communication Among the Gut, Brain, and Beyond

  2025cites this paper
• The Relationship Between Grip Strength and Cognitive Impairment: Evidence From NHANES 2011–2014

  2025cites this paper
• Probiotic-fermented ginger-processed Gastrodia elata BI. Ameliorates AlCl3-induced cognitive dysfunction in an Alzheimer's disease rat model by regulating the gut microbiota and CREB/BDNF pathway.

  2025cites this paper
• A retrospective study on blood microbiota as a marker for cognitive decline: implications for detecting Alzheimer’s disease and amnestic mild cognitive impairment in Republic of Korea

  2025cites this paper
• Microbial diversity and fitness in the gut–brain axis: influences on developmental risk for Alzheimer’s disease

  2025cites this paper
• The impact of inflammatory bowel disease on dementia risk: a current systematic review and meta-analysis

  2025cites this paper
• Comprehensive analysis of gut microbiota and fecal metabolites in patients with autism spectrum disorder

  2025cites this paper
• Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

  2025cites this paper
• Interlinking Diabetes and Alzheimer's Disease: A Pathway Through Medicinal Plant-Based Treatments.

  2025cites this paper
• Neuroprotective and probiotic potential of Lactiplantibacillus plantarum AM2 in cognitive impairment

  2025cites this paper
• Microbiota–gut–brain axis and anxiety or depression: A perspective from bibliometric and visual analysis

  2025cites this paper
• The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer’s Disease

  2025cites this paper
• Comparing and optimizing protein extraction methods with different lysis buffers for the analyses of human fecal microbiome via metaproteomics approach.

  2025cites this paper
• Ketogenic Diet Mitigates Age-Related Cognitive Decline and Neuroinflammation in Rats, While Antibiotics Exacerbate Brain Health Risks

  2025cites this paper
• Mendelian analysis reveals novel pancreatic cancer-associated gut bacteria with tumor-suppressive effects

  2025cites this paper
• Microbiome–Gut–Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders

  2025cites this paper
• The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review

  2025cites this paper
• Gut Microbiota Alterations and Their Impact on Alzheimer’s disease Progression: Review article

  2025influential citation
• The Gut Brain Axis and Cognitive Decline: A Narrative Review of Microbiota Dynamics in MCI and Alzheimer’s Disease

  2025cites this paper
• Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

  2025cites this paper
• The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer’s Disease: A Systematic Review

  2025cites this paper
• Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease

  2025cites this paper
• From Gut to Brain: The Impact of Short-Chain Fatty Acids on Brain Cancer

  2025cites this paper
• Age-Related Changes in Gut Health and Behavioral Biomarkers in a Beagle Dog Population

  2025cites this paper
• Dual-Functional Synthetic Linear and Cyclic Peptides with Anti-Amyloid and Antimicrobial Activities for Alzheimer's disease.

  2025cites this paper
• Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum

  2025cites this paper
• Gut–Brain Axis and Brain Microbiome Interactions from a Medical Perspective

  2025cites this paper
• Neuroglia and the microbiota-gut-brain axis.

  2025cites this paper
• Lactobacillus Combined with Inulin Ameliorated Memory Deficit by Modulating Gut Microbiota and Metabolic Profiles

  2025cites this paper
• Crocin Ameliorates Cognitive Impairment and Pathological Changes in Alzheimer's Disease Model Mice by Regulating Gut Microbiota

  2025cites this paper
• Alterations in gut microbiota and plasma metabolites: a multi-omics study of mild cognitive impairment in Parkinson’s disease

  2025cites this paper
• Pathogenic bacterium Citrobacter braakii isolated from Procambarus clarkii triggers oxidative stress, apoptosis, and changes in the intestinal microbiome and metabolome

  2025cites this paper
• Progress in the investigation of the Firmicutes/Bacteroidetes ratio as a potential pathogenic factor in ulcerative colitis.

  2025cites this paper
• Investigating gut alterations in Alzheimer’s disease: In-depth analysis with micro- and nano-3D X-ray phase contrast tomography

  2025cites this paper
• Lactobacillus paracasei GF027 promotes growth and cognitive development in juvenile rats via regulating intestinal microecology and nourishing the brain

  2025cites this paper
• The impact of probiotics therapy on cognitive and metabolic characteristics in patients with cognitive impairment: An umbrella review of meta-analysis of randomized controlled trials.

  2025cites this paper
• Bridging gap in the treatment of Alzheimer's disease via postbiotics: Current practices and future prospects.

  2025cites this paper
• Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders

  2025cites this paper
• The comparison of gut microbiota between different types of epilepsy in children

  2025cites this paper
• The Application of DNA Viruses to Biotechnology

  2025cites this paper
• Gut Microbiota and Alzheimer Disease.

  2025cites this paper
• Rice bran extract ameliorate heavy metal mixture induced hippocampal toxicity via inhibiting oxido-inflammatory damages and modulating Hmox-1/BDNF/Occludin/Aβ40/Aβ42 in rats.

  2025cites this paper
• The mechanistic action of mogroside V in the alleviation of oxidative aging

  2025cites this paper
• Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies.

  2025cites this paper
• Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential

  2025cites this paper
• Combating depression with rosemary (Rosmarinus officinalis L.)-derived polyphenols: Major phytochemicals, functional properties, and potential.

  2025cites this paper
• Association of Mediterranean, high-quality, and anti-inflammatory diet with dementia in UK Biobank cohort

  2025cites this paper
• The Impact of Alcohol on the Gut Microbiota: A literature review

  2025cites this paper
• Restoring Gut-brain Function by Medicinal Herbs Offering Neuroprotection through Suppressing Inflammatory Pathways: A Systematic Review

  2025cites this paper
• Acrylamide Impacts on Black Soldier Fly Larvae: Growth, Toxicity, Microbes, and Bioaccumulation Risks for Food/Feed Safety

  2025cites this paper
• Biomedical Treatment Nanomotors Based on the Intestinal Axis: Current Challenges.

  2025cites this paper
• Potential common pathogenesis of several neurodegenerative diseases

  2025cites this paper
• TET2-mutant myeloid cells mitigate Alzheimer's disease progression via CNS infiltration and enhanced phagocytosis in mice.

  2025cites this paper
• Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.

  2025cites this paper
• The MR1/MAIT cell axis impacts the gut–brain axis through both cognition and microbial community structure in 5XFAD mice

  2025cites this paper
• An Olsalazine-Loaded Hollow Mesoporous Prussian Blue/Polydopamine Nanozyme Alleviates Anxiety/Depression-like Behavior and Enhances Brain Neural Activity in Colitis Mice.

  2025cites this paper
• Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders

  2025cites this paper
• Non-invasive and sensitive MRI assessment of radiation-induced cognitive dysfunction via voxel-based morphological and functional connectivity

  2025cites this paper
• Microbial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential

  2025cites this paper
• The Role of Diet, Gut Microbiome, and Inflammation in Vascular Dementia: a mini review

  2025cites this paper
• Probiotics and Cognitive-Related Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials.

  2025cites this paper
• KADAIF: an anomaly detection method for complex microbiome data

  2025cites this paper
• Fibre supplementation alters the gastrointestinal microbiome, the microbial metabolites and indicators of neurodegeneration in a mouse model of Alzheimer´s disease

  2025cites this paper
• Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease.

  2024cites this paper
• Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer’s disease

  2024cites this paper
• Regulation of colonic neuropeptide Y expression by the gut microbiome in patients with ulcerative colitis and its association with anxiety- and depression-like behavior in mice

  2024cites this paper
• Fecal microbiota transplantation unveils sex-specific differences in a controlled cortical impact injury mouse model

  2024cites this paper
• Increased IgA-mediated responses to the gut paracellular pathway and blood–brain barrier proteins predict delirium due to hip fracture in older adults

  2024cites this paper
• Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation.

  2024cites this paper
• The bidirectional links between coronavirus disease 2019 and Alzheimer’s disease

  2024cites this paper